Guru Ownership Trend
Guru Analysis for Abbott Laboratories (ABT)
Abbott Laboratories (ABT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 20 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.43 B.
Top institutional holders include Jeremy Grantham and Diamond Hill Capital.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $192.72 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 166.6%. Conversely, Jefferies Group reduced exposure by 93.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Abbott Laboratories (ABT)
Major holders include Jeremy Grantham ($797.97 M), Diamond Hill Capital ($447.96 M), Cliff Asness ($380.48 M). According to the latest reported data, 20 tracked investment managers collectively hold approximately 23.8 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $192.72 M, with 9 managers increasing positions and 10 managers reducing holdings.
During the most recent reporting period, 9 managers trimmed their positions, while 1 fully exited ABT. The total reported sell value was $322.13 M.
Yes, 2 managers opened new positions in ABT, and 7 increased their existing holdings. The total reported buy value was $514.84 M.
